Shell Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$9.3M Sell
12,193
-32,044
-72% -$23.8M 0.93% 12
2025
Q2
$34.5M Buy
44,237
+9,433
+27% +$7.33M 1.19% 13
2025
Q1
$28.7M Sell
34,804
-1,343
-4% -$1.12M 1.36% 11
2024
Q4
$27.9M Sell
36,147
-1,976
-5% -$1.64M 1.22% 13
2024
Q3
$33.8M Buy
+38,123
New +$34.3M 1.49% 8
2024
Q1
$37.3M Sell
41,172
-3,934
-9% -$2.8M 1.7% 7
2023
Q4
$26.3M Sell
45,106
-12,465
-22% -$7.28M 1.21% 11
2023
Q3
$30.9M Sell
57,571
-1,194
-2% -$615K 1.28% 11
2023
Q2
$27.6M Buy
58,765
+5,419
+10% +$2.27M 1.09% 12
2023
Q1
$18.3M Buy
53,346
+5,498
+11% +$1.85M 0.76% 20
2022
Q4
$17.5M Sell
47,848
-9,516
-17% -$3.37M 0.77% 21
2022
Q3
$18.5M Sell
57,364
-12,561
-18% -$3.98M 0.72% 19
2022
Q2
$22.7M Buy
69,925
+10,501
+18% +$3.15M 0.67% 21
2022
Q1
$17M Sell
59,424
-3,607
-6% -$928K 0.4% 49
2021
Q4
$17.4M Sell
63,031
-8,356
-12% -$2.12M 0.36% 51
2021
Q3
$16.5M Sell
71,387
-18,057
-20% -$4.46M 0.37% 47
2021
Q2
$20.5M Sell
89,444
-9,612
-10% -$1.93M 0.4% 43
2021
Q1
$18.5M Sell
99,056
-22,304
-18% -$4.36M 0.37% 57
2020
Q4
$20.5M Sell
121,360
-4,229
-3% -$631K 0.42% 35
2020
Q3
$18.6M Sell
125,589
-628
-0.5% -$97.2K 0.43% 40
2020
Q2
$20.7M Buy
126,217
+10,848
+9% +$1.67M 0.52% 34
2020
Q1
$16M Sell
115,369
-2,594
-2% -$356K 0.45% 43
2019
Q4
$15.5M Sell
117,963
-14,341
-11% -$1.66M 0.33% 62
2019
Q3
$14.8M Sell
132,304
-6,969
-5% -$776K 0.34% 65
2019
Q2
$15.4M Sell
139,273
-7,935
-5% -$934K 0.34% 62
2019
Q1
$19.1M Sell
147,208
-48,816
-25% -$5.94M 0.42% 45
2018
Q4
$22.7M Sell
196,024
-31,131
-14% -$3.48M 0.57% 34
2018
Q3
$24.4M Sell
227,155
-15,245
-6% -$1.52M 0.48% 37
2018
Q2
$20.7M Sell
242,400
-50,696
-17% -$4.16M 0.42% 48
2018
Q1
$22.7M Buy
293,096
+3,554
+1% +$286K 0.45% 45
2017
Q4
$24.5M Buy
289,542
+506
+0.2% +$43.1K 0.49% 42
2017
Q3
$24.7M Sell
289,036
-20,468
-7% -$1.68M 0.55% 35
2017
Q2
$25.5M Buy
309,504
+1,021
+0.3% +$83.3K 0.54% 37
2017
Q1
$25.9M Buy
308,483
+20,242
+7% +$1.62M 0.57% 34
2016
Q4
$21.2M Sell
288,241
-29,697
-9% -$2.21M 0.5% 43
2016
Q3
$25.5M Buy
317,938
+28,557
+10% +$2.29M 0.53% 39
2016
Q2
$22.8M Buy
289,381
+13,882
+5% +$1.05M 0.53% 43
2016
Q1
$19.8M Sell
275,499
-14,636
-5% -$1.11M 0.48% 52
2015
Q4
$24.4M Sell
290,135
-101,504
-26% -$8.42M 0.58% 28
2015
Q3
$25.4M Buy
391,639
+19,462
+5% +$1.64M 0.4% 46
2015
Q2
$31.1M Sell
372,177
-81,337
-18% -$6.2M 0.62% 28
2015
Q1
$32.9M Buy
453,514
+40,981
+10% +$2.92M 0.57% 32
2014
Q4
$28.5M Buy
412,533
+20,894
+5% +$1.41M 0.46% 42
2014
Q3
$25.4M Buy
391,639
+773
+0.2% +$48.9K 0.39% 46
2014
Q2
$24.3M Sell
390,866
-181,990
-32% -$10.9M 0.37% 51
2014
Q1
$33.7M Buy
572,856
+9,689
+2% +$541K 0.56% 22
2013
Q4
$28.7M Buy
563,167
+67,977
+14% +$3.4M 0.49% 23
2013
Q3
$24.9M Buy
495,190
+22,688
+5% +$1.19M 0.46% 37
2013
Q2
$23.2M Buy
+472,502
New +$25.7M 0.44% 38

Other funds holding LLY

Shell Asset Management's LLY Position: Q3 2025 in Review

Shell Asset Management reduced its Eli Lilly (LLY) stake by 72% in Q3 2025, selling an estimated $23.8M and leaving 12,193 shares worth $9.3M. The position accounts for 0.93% of the portfolio, ranked #12.

Shell Asset Management first reported a position in LLY in Q2 2013 and has held it in 49 quarters since. The position peaked at $37.3M in Q1 2024. 3,898 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Shell Asset Management held 12,193 shares of Eli Lilly worth $9.3M as of Q3 2025.
  • Shell Asset Management sold 32,044 Eli Lilly shares in Q3 2025, an estimated $23.8M.
  • Eli Lilly made up 0.93% of Shell Asset Management's portfolio in Q3 2025, its #12 holding.
  • Shell Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 49 quarters since.
  • Shell Asset Management's Eli Lilly position peaked at $37.3M in Q1 2024.
  • 3,898 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.